Antinuclear antibodies in schizophrenia and major depressive disorder - a lasting puzzle

Author： Schott K.   Uhl A.   Batra A.   Bartels M.   Eusterschulte B.   Buchkremer G.  

Publisher： Elsevier

ISSN： 0924-9338

Source： European Psychiatry, Vol.11, Iss.5, 1996-01, pp. : 263-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis

By  

World Psychiatry, Vol. 15, Iss. 2, 2016-06 ,pp. : 166-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self‐Reported and Interviewer‐Rated Oral Health in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

By  

PERSPECTIVES IN PSYCHIATRIC CARE, Vol. 52, Iss. 1, 2016-01 ,pp. : 4-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

By  

World Psychiatry, Vol. 1723-8617, Iss. 3, 2015-10 ,pp. : 339-347

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

By  

World Psychiatry, Vol. 14, Iss. 3, 2015-10 ,pp. : 339-347

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching to Bupropion in Fluoxetine-Resistant Major Depressive Disorder

By Fava M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 15, Iss. 1, 2003-03 ,pp. : 17-22

Springer Publishing Company

Access to resources Recommend Favorite